Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-06-2022 | Empagliflozin | Case report

Empagliflozin

Hypoglycaemic seizure, loss of previously established metabolic control and excessive thirst: 3 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Halligan RK, et al. Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre. Orphanet Journal of Rare Diseases 17: 195, No. 1, Dec 2022. Available from: URL: http://www.ojrd.com/ Halligan RK, et al. Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre. Orphanet Journal of Rare Diseases 17: 195, No. 1, Dec 2022. Available from: URL: http://​www.​ojrd.​com/​
Metadata
Title
Empagliflozin
Hypoglycaemic seizure, loss of previously established metabolic control and excessive thirst: 3 case reports
Publication date
01-06-2022
Publisher
Springer International Publishing
Keyword
Empagliflozin
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-17909-0

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Multiple drugs

Case report

Bupivacaine

Case report

Antineoplastics